Top Page
WuXi XDC Cayman, Inc.
(2268)
WuXi XDC Cayman, Inc. (2268) vs. iShares MSCI Hong Kong ETF (EWH)
WuXi XDC Cayman, Inc. Business Overview & Revenue Model
WuXi XDC Cayman, Inc. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.09B | 4.05B | 2.12B | 990.42M | 311.13M | 96.35M |
| Gross Profit | 1.68B | 1.24B | 559.56M | 261.08M | 113.49M | 8.08M |
| EBITDA | 1.42B | 1.33B | 420.28M | 151.75M | 77.37M | 7.10M |
| Net Income | 1.33B | 1.07B | 283.54M | 155.73M | 54.93M | 26.30M |
Balance Sheet | ||||||
| Total Assets | 10.62B | 9.12B | 6.74B | 2.50B | 879.75M | 408.47M |
| Cash, Cash Equivalents and Short-Term Investments | 4.54B | 3.97B | 4.05B | 734.97M | 26.32M | 28.39M |
| Total Debt | 1.04B | 496.43M | 2.84M | 77.18M | 24.59M | 0.00 |
| Total Liabilities | 3.18B | 2.48B | 1.28B | 1.02B | 858.87M | 32.79M |
| Stockholders Equity | 7.44B | 6.64B | 5.45B | 1.48B | 20.88M | 375.68M |
Cash Flow | ||||||
| Free Cash Flow | -99.81M | -787.95M | -206.51M | 50.43M | 7.23M | -32.03M |
| Operating Cash Flow | 1.54B | 717.22M | 332.85M | 251.82M | 59.14M | 20.85M |
| Investing Cash Flow | -5.00B | -3.33B | -91.23M | -1.28B | -51.59M | -52.42M |
| Financing Cash Flow | 967.91M | 475.36M | 3.52B | 1.33B | 22.34M | 69.12M |
WuXi XDC Cayman, Inc. Technical Analysis
WuXi XDC Cayman, Inc. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | HK$329.37B | 21.68 | 25.65% | 0.34% | 11.55% | 64.46% | |
| ― | HK$88.33B | 59.12 | 19.62% | ― | ― | ― | |
| ― | HK$24.46B | 41.20 | 3.79% | 0.17% | -17.13% | 125.91% | |
| ― | €45.84B | 112.35 | 2.72% | 0.75% | -3.81% | -34.76% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
WuXi XDC Cayman, Inc. Corporate Events
WuXi XDC Cayman Inc. has completed a connected transaction involving the subscription of new shares under a specific mandate. On October 22, 2025, WuXi Biologics successfully subscribed to 24,134,000 new shares at a price of HK$58.85 per share, resulting in net proceeds of approximately HK$1,414.47 million. This transaction has increased WuXi Biologics’ shareholding in the company from 49.75% to 50.72%, slightly altering the company’s shareholding structure.
The most recent analyst rating on (HK:2268) stock is a Hold with a HK$63.30 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman Inc. announced the successful passing of a resolution at their Extraordinary General Meeting held on October 9, 2025. The resolution involved a subscription agreement with WuXi Biologic (Cayman) Inc. for the issuance of 24,134,000 new shares at HK$58.85 per share, which was unanimously approved by the shareholders. This agreement is expected to strengthen WuXi XDC’s capital base and enhance its strategic positioning in the market.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$90.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman, Inc. has announced revisions to its annual caps for existing connected transactions (CCTs) and plans to renew these agreements for an additional three years, reflecting its strong financial performance and anticipated demand. The company also proposes new CCTs to maximize its manufacturing capacity, subject to regulatory requirements, indicating a strategic move to sustain its growth trajectory and strengthen its market position.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$73.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman Inc. has announced an extraordinary general meeting to approve a subscription agreement with WuXi Biologic (Cayman) Inc. The agreement involves issuing 24,134,000 new shares at HK$58.85 each, which is expected to enhance the company’s capital structure and support its growth initiatives.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$73.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman Inc. has announced the closure of its register of members in anticipation of an Extraordinary General Meeting (EGM) scheduled for October 9, 2025. This meeting will allow independent shareholders to consider and potentially approve a Subscription Agreement and related transactions. The register will be closed from October 6 to October 9, 2025, during which no share transfers will be registered, ensuring that only eligible shareholders can attend and vote at the EGM.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$73.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman Inc. has entered into a Subscription Agreement to issue and allot 24,134,000 new shares to a controlling shareholder at a price of HK$58.85 per share, totaling approximately HK$1,420.29 million. This transaction, constituting a connected transaction under the Listing Rules, requires approval from independent shareholders and involves the establishment of an Independent Board Committee and the appointment of an Independent Financial Adviser to ensure compliance and transparency.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$74.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman, Inc. has announced the placement of up to 22,277,000 new shares under a general mandate, with the shares priced at HK$58.85 each. This move is expected to raise approximately HK$1,311.00 million in gross proceeds. The placement, which represents about 1.85% of the company’s existing issued share capital, is subject to certain conditions and will involve at least six independent third-party investors. The company plans to apply for the listing of these new shares on the Stock Exchange, although the completion of the placement is not guaranteed.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$74.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman, Inc. has announced a revision and renewal of its Payload-Linkers Master Services Agreement due to the strong growth in its ADC CRDMO business. The company anticipates exceeding its original annual cap for 2025 and plans to extend the agreement with WuXi AppTec for three more years, subject to regulatory requirements. This move reflects the company’s robust performance and strategic positioning in the market, aiming to capitalize on the increasing demand for its services.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$74.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman Inc. has announced the approval of a grant of 110,543 restricted shares to seven employees under its 2024 Share Scheme. This initiative is designed to motivate employees by providing them with a personal stake in the company, thereby enhancing their performance and efficiency. The shares will vest over a five-year period, with no additional performance targets required. The grant aligns with the company’s customary equity-based remuneration practices and does not require shareholder approval.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$70.70 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman Inc. has announced that it will hold conference calls on August 19, 2025, to present its 2025 interim financial results and business operations. The company aims to provide shareholders and potential investors with a comprehensive understanding of its performance and strategic direction. The presentation will be accessible in both Chinese and English to ensure equal and timely access to information for all stakeholders.
The most recent analyst rating on (HK:2268) stock is a Hold with a HK$28.20 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
WuXi XDC Cayman, Inc. reported significant financial growth for the first half of 2025, with revenue increasing by 62.2% to RMB2,700.9 million and gross profit rising by 82.2% to RMB975.2 million. The company’s net profit attributable to owners also saw a 52.7% increase, reaching RMB745.7 million. Despite these positive results, the Board has decided not to recommend any interim dividend payment for this period.
The most recent analyst rating on (HK:2268) stock is a Hold with a HK$28.20 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.